NCT05522387 2026-02-27
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Inmune Bio, Inc.
Phase 2 Terminated
Inmune Bio, Inc.
Virginia Commonwealth University
Baptist Health South Florida
Hospices Civils de Lyon
University of Seville
Haseki Training and Research Hospital
Deepsonbio
University of Aarhus
St. Jude Children's Research Hospital
Peking University First Hospital